Abbott Laboratories (NYSE:ABT) was upgraded to Buy from Hold at Jefferies following its Q2 results and revised guidance, as analysts view the market reaction as “overly punitive” and see an attractive ...

In today’s ever-changing global financial markets, forex trading is no longer reserved for institutional giants. Jefferies ...

Copilot continues to be adopted by enterprises at a decent clip and could reach $11B in revenue for the company during ...

The veteran analyst reiterated his belief that the recent geopolitics-fueled rally in rates was the start of prolonged ...